Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Acute flexor tendon transection in zone 2 in digits 2, 3, 4, or 5 (diagnosed within 1 week after the injury)~* Age over 18~* Patient's willingness to participate in the study~Exclusion Criteria:~* Tendon transection within 8 mm of its distal insertion (requiring reinsertion)~* Soft-tissue loss, severe crush, fracture, palmar plate injury, patient requiring revascularization~* Cognitive impairment or other factors (prisoner, military serviceman) which may affect one's decision making~* Substance abuse~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Amniotic membrane allograft group (Type: EXPERIMENTAL): After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.

Based on this trial design, predict the completion outcome and termination type (if applicable).